Rebecca Dent
Breast medical oncologist and Deputy CEO for clinical operations at the National Cancer Centre Singapore, an international leader in triple-negative breast cancer trials.
Overview
Rebecca Dent is Deputy Chief Executive Officer for clinical operations at the National Cancer Centre Singapore and a senior consultant in medical oncology. Her research focuses on triple-negative and early breast cancer, and she has been a lead investigator on international phase 3 trials of immunotherapy and targeted agents in breast cancer. She chairs and contributes to international breast cancer guideline and consensus groups.
Pages like this
not linked directly; found by shared links- PersonEva Ciruelos
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonDorraya El-Ashry
Shares Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonSunil Lakhani
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonPriya Rastogi
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonIsabel T. Rubio
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonSuzette Delaloge
Shares HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonAnna Sapino
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonTari A. King
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.